The UK healthcare sector is a major beneficiary of EU R&D funding, free-movement of scientists, and a regulatory framework that expedites product approvals across the continent, writes Quilter Cheviot's Amish Patel.
In the latest in our series of interviews with some of the industry's key Investment Influencers, Investment Week talks to Jonathan Bell, partner and CIO of Stanhope Capital.
No change to QE programme
In the latest in our series of interviews with some of the industry's key Investment Influencers, Investment Week talks to Richard Romer-Lee of Square Mile Investment Consulting & Research.
With all three rating agencies lowering growth expectations for the domestic economy following the referendum result last month, the attractions of investing for long-term growth in the technology related sectors has again been highlighted in our view....
Firms entering "uncharted waters"
Higher domestic exposure than FTSE 100